Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells
- PMID: 9406980
- DOI: 10.1016/s0006-8993(97)00827-5
Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells
Abstract
Deposition of beta-amyloid (A beta) is a characteristic feature of the pathology of Alzheimer's disease (AD). Since glucose metabolism and the consequential ATP production are depressed in the temporal and parietal regions of the cortex in patients with AD, we designed the present study to investigate the possible role of hypometabolism in the pathogenesis of AD. We incubated rat primary cortical astroglial cells for 2 h to 4 days in a media deprived of 95% of its glucose and assessed the expression and alternative splicing of the mRNA that encoding beta-amyloid precursor protein (APP) using RT-PCR. Hypoglycemia caused a time-dependent increase in APP mRNA expression, which reaches a peak level of 173.2% of control expression (P < 0.05) at 24 h of hypoglycemia. Noteworthy, hypoglycemia favors the alternative splicing that includes the exon 7 segment, which encodes a Kunitz-type serine protease inhibitor domain. This study demonstrates that hypoglycemia increases APP mRNA expression in astroglial cells and processing of APP mRNA to a form that may encourage A beta deposits in AD. These data suggest that the observed hypometabolism in AD may contribute to its deposition of A beta in affected brain regions.
Similar articles
-
Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures.Neurosci Lett. 1995 Mar 16;188(1):70-4. doi: 10.1016/0304-3940(95)11384-9. Neurosci Lett. 1995. PMID: 7783982
-
Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain.J Mol Neurosci. 1995;6(4):257-76. doi: 10.1007/BF02736785. J Mol Neurosci. 1995. PMID: 8860237
-
Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.Endocrinology. 2011 Jul;152(7):2704-15. doi: 10.1210/en.2011-0145. Epub 2011 May 10. Endocrinology. 2011. PMID: 21558319
-
The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia.J Neurosci Res. 1990 Mar;25(3):431-40. doi: 10.1002/jnr.490250321. J Neurosci Res. 1990. PMID: 2109094
-
The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.Prog Clin Biol Res. 1989;317:971-84. Prog Clin Biol Res. 1989. PMID: 2513588 Review.
Cited by
-
The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.J Clin Med. 2020 Jan 12;9(1):206. doi: 10.3390/jcm9010206. J Clin Med. 2020. PMID: 31940879 Free PMC article. Review.
-
Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.Front Neurosci. 2018 Jan 5;11:728. doi: 10.3389/fnins.2017.00728. eCollection 2017. Front Neurosci. 2018. PMID: 29354027 Free PMC article. Review.
-
Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.BMC Neurosci. 2008 Dec 3;9 Suppl 2(Suppl 2):S2. doi: 10.1186/1471-2202-9-S2-S2. BMC Neurosci. 2008. PMID: 19090990 Free PMC article. Review.
-
Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.Genome Biol. 2008 Oct 8;9(10):R148. doi: 10.1186/gb-2008-9-10-r148. Genome Biol. 2008. PMID: 18842138 Free PMC article.
-
Iron: the Redox-active center of oxidative stress in Alzheimer disease.Neurochem Res. 2007 Oct;32(10):1640-5. doi: 10.1007/s11064-007-9360-7. Epub 2007 May 17. Neurochem Res. 2007. PMID: 17508283 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
